Company intelligence / Profile preview

Orthofix

Ownership: Public · OFIX
Employees: ~1000
Development stage: Commercial

Overview

Orthofix has a broad commercial portfolio of FDA-cleared and CE-marked products for spine surgery and orthopedics. Its offerings include spinal hardware systems for fixation and motion preservation, biologic allografts for bone fusion enhancement, external fixation devices for limb reconstruction/trauma care, and advanced surgical navigation technologies. The company’s solutions are supported by clinical evidence and distributed in over 70 countries[1][2][4][5].

Therapeutic areas: OtherNeurologyRheumatology
Modalities: DeviceBiologicElectromagnetic therapy
Industry: Implantable Medical Devices

Partnerships

MTF BiologicsTexas Scottish Rite Hospital for ChildrenOrthopedic Research and Education Foundation

Financials

Market cap: $360.2M
Total revenue: $210.9M
Enterprise value: $491M

Beyond the preview

Go deeper on Orthofix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orthofix.

Explore the full profile